{"count": 7, "results": [{"_id": "32628589", "pmid": 32628589, "title": "Effects of Antidiabetic Drugs on Muscle Mass in Type 2 Diabetes Mellitus.", "journal": "Curr Diabetes Rev", "authors": ["Ida S", "Kaneko R", "Imataka K", "Okubo K", "Shirakura Y", "Azuma K", "Fujiwara R", "Murata K"], "date": "2021-01-01T00:00:00Z", "doi": "10.2174/1573399816666200705210006", "meta_date_publication": "2021", "meta_volume": "17", "meta_issue": "3", "meta_pages": "293-303", "score": 50259.27, "text_hl": "OBJECTIVE: To comparatively examine the effects of GLP-1RAs and oral antidiabetic drugs, including @GENE_SLC5A2 @GENE_6524 @@@SGLT2@@@ inhibitors and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, on @<m>DISEASE_MASS_syndrome</m> @DISEASE_MESH:C536030 @@@muscle mass@@@ and body weight in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ via a network meta-analysis of randomized controlled trials. ", "citations": {"NLM": "Ida S, Kaneko R, Imataka K, Okubo K, Shirakura Y, Azuma K, Fujiwara R, Murata K. Effects of Antidiabetic Drugs on Muscle Mass in Type 2 Diabetes Mellitus. Curr Diabetes Rev. 2021;17(3):293-303. PMID: 32628589", "BibTeX": "@article{32628589, title={Effects of Antidiabetic Drugs on Muscle Mass in Type 2 Diabetes Mellitus.}, author={Ida S and Kaneko R and Imataka K and Okubo K and Shirakura Y and Azuma K and Fujiwara R and Murata K}, journal={Curr Diabetes Rev}, volume={17}, number={3}, pages={293-303}}"}}, {"_id": "31751310", "pmid": 31751310, "pmcid": "PMC6933833", "title": "Metformin ameliorates body mass gain and early metabolic changes in ovariectomized rats", "journal": "Endocr Connect", "authors": ["Barthem CS", "Rossetti CL", "Carvalho DP", "da-Silva WS"], "date": "2019-12-01T00:00:00Z", "doi": "10.1530/EC-19-0470", "meta_date_publication": "2019 Dec", "meta_volume": "8", "meta_issue": "12", "meta_pages": "1568-1578", "score": 50067.7, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ ameliorates @<m>DISEASE_MASS_syndrome</m> @DISEASE_MESH:C536030 @@@body mass gain@@@ and early metabolic changes in ovariectomized rats", "citations": {"NLM": "Barthem CS, Rossetti CL, Carvalho DP, da-Silva WS. Metformin ameliorates body mass gain and early metabolic changes in ovariectomized rats Endocr Connect. 2019 Dec;8(12):1568-1578. PMID: 31751310", "BibTeX": "@article{31751310, title={Metformin ameliorates body mass gain and early metabolic changes in ovariectomized rats}, author={Barthem CS and Rossetti CL and Carvalho DP and da-Silva WS}, journal={Endocr Connect}, volume={8}, number={12}, pages={1568-1578}}"}}, {"_id": "31814870", "pmid": 31814870, "pmcid": "PMC6877950", "title": "Long-Term Moderate Exercise Combined with Metformin Treatment Induces an Hormetic Response That Prevents Strength and Muscle Mass Loss in Old Female Wistar Rats", "journal": "Oxid Med Cell Longev", "authors": ["Hernández-Álvarez D", "Mena-Montes B", "Toledo-Pérez R", "Pedraza-Vázquez G", "López-Cervantes SP", "Morales-Salazar A", "Hernández-Cruz E", "Lazzarini-Lechuga R", "Vázquez-Cárdenas RR", "Vilchis-DeLaRosa S", "Posadas-Rodríguez P", "Santín-Márquez R", "Rosas-Carrasco O", "Ibañez-Contreras A", "Alarcón-Aguilar A", "López-Díazguerrero NE", "Luna-López A", "Königsberg M"], "date": "2019-11-11T00:00:00Z", "doi": "10.1155/2019/3428543", "meta_date_publication": "2019", "meta_volume": "2019", "meta_issue": "", "meta_pages": "3428543", "score": 50053.105, "text_hl": "Long-Term Moderate Exercise Combined with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Treatment Induces an Hormetic Response That Prevents Strength and @<m>DISEASE_MASS_syndrome</m> @DISEASE_MESH:C536030 @@@Muscle Mass Loss@@@ in Old Female Wistar Rats", "citations": {"NLM": "Hernández-Álvarez D, Mena-Montes B, Toledo-Pérez R, Pedraza-Vázquez G, López-Cervantes SP, Morales-Salazar A, Hernández-Cruz E, Lazzarini-Lechuga R, Vázquez-Cárdenas RR, Vilchis-DeLaRosa S, Posadas-Rodríguez P, Santín-Márquez R, Rosas-Carrasco O, Ibañez-Contreras A, Alarcón-Aguilar A, López-Díazguerrero NE, Luna-López A, Königsberg M. Long-Term Moderate Exercise Combined with Metformin Treatment Induces an Hormetic Response That Prevents Strength and Muscle Mass Loss in Old Female Wistar Rats Oxid Med Cell Longev. 2019;2019():3428543. PMID: 31814870", "BibTeX": "@article{31814870, title={Long-Term Moderate Exercise Combined with Metformin Treatment Induces an Hormetic Response That Prevents Strength and Muscle Mass Loss in Old Female Wistar Rats}, author={Hernández-Álvarez D and Mena-Montes B and Toledo-Pérez R and Pedraza-Vázquez G and López-Cervantes SP and Morales-Salazar A and Hernández-Cruz E and Lazzarini-Lechuga R and Vázquez-Cárdenas RR and Vilchis-DeLaRosa S and Posadas-Rodríguez P and Santín-Márquez R and Rosas-Carrasco O and Ibañez-Contreras A and Alarcón-Aguilar A and López-Díazguerrero NE and Luna-López A and Königsberg M}, journal={Oxid Med Cell Longev}, volume={2019}, pages={3428543}}"}}, {"_id": "15483105", "pmid": 15483105, "title": "Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy.", "journal": "J Clin Endocrinol Metab", "authors": ["Ibáñez L", "de Zegher F"], "date": "2005-01-01T00:00:00Z", "doi": "10.1210/jc.2004-1405", "meta_date_publication": "2005 Jan", "meta_volume": "90", "meta_issue": "1", "meta_pages": "39-43", "score": 50051.895, "text_hl": "@CHEMICAL_Flutamide @CHEMICAL_MESH:D005485 @@@Flutamide@@@ (@CHEMICAL_Flutamide @CHEMICAL_MESH:D005485 @@@Flu@@@)-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@GENE_SLTM @GENE_79811 @@@Met@@@) with @CHEMICAL_drospirenone_and_ethinyl_estradiol_combination @CHEMICAL_MESH:C534342 @@@ethinylestradiol-drospirenone@@@ is a combination therapy that reduces the total and abdominal fat excess, diminishes the lean @<m>DISEASE_MASS_syndrome</m> @DISEASE_MESH:C536030 @@@mass deficit@@@, and attenuates the dysadipocytokinemia of young and nonobese @SPECIES_9606 @@@women@@@ with @DISEASE_Ovarian_Diseases @DISEASE_MESH:D010049 @@@ovarian hyperandrogenism@@@, a variant of @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@. ", "citations": {"NLM": "Ibáñez L, de Zegher F. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy. J Clin Endocrinol Metab. 2005 Jan;90(1):39-43. PMID: 15483105", "BibTeX": "@article{15483105, title={Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy.}, author={Ibáñez L and de Zegher F}, journal={J Clin Endocrinol Metab}, volume={90}, number={1}, pages={39-43}}"}}, {"_id": "31886264", "pmid": 31886264, "pmcid": "PMC6899291", "title": "Role of Metformin on Osteoblast Differentiation in Type 2 Diabetes", "journal": "Biomed Res Int", "authors": ["Jiating L", "Buyun J", "Yinchang Z"], "date": "2019-11-26T00:00:00Z", "doi": "10.1155/2019/9203934", "meta_date_publication": "2019", "meta_volume": "2019", "meta_issue": "", "meta_pages": "9203934", "score": 50049.316, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, an effective hypoglycemic, can modulate different points of @<m>DISEASE_MASS_syndrome</m> @DISEASE_MESH:C536030 @@@malignant mass@@@, @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@ (@DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@), @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular diseases@@@, @DISEASE_Tuberculosis @DISEASE_MESH:D014376 @@@tuberculosis@@@, and nerve regeneration. ", "citations": {"NLM": "Jiating L, Buyun J, Yinchang Z. Role of Metformin on Osteoblast Differentiation in Type 2 Diabetes Biomed Res Int. 2019;2019():9203934. PMID: 31886264", "BibTeX": "@article{31886264, title={Role of Metformin on Osteoblast Differentiation in Type 2 Diabetes}, author={Jiating L and Buyun J and Yinchang Z}, journal={Biomed Res Int}, volume={2019}, pages={9203934}}"}}, {"_id": "30815567", "pmid": 30815567, "pmcid": "PMC6354841", "title": "Melatonin potentiates the effects of metformin on glucose metabolism and food intake in high-fat-fed rats", "journal": "Endocrinol Diabetes Metab", "authors": ["Dantas-Ferreira RF", "Raingard H", "Dumont S", "Schuster-Klein C", "Guardiola-Lemaitre B", "Pevet P", "Challet E"], "date": "2018-08-31T00:00:00Z", "doi": "10.1002/edm2.39", "meta_date_publication": "2018 Oct", "meta_volume": "1", "meta_issue": "4", "meta_pages": "e00039", "score": 50041.094, "text_hl": "To assess whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-induced @<m>DISEASE_MASS_syndrome</m> @DISEASE_MESH:C536030 @@@body mass loss@@@ is exclusively due to its anorectic effects will require additional experiments of pair-feeding. ", "citations": {"NLM": "Dantas-Ferreira RF, Raingard H, Dumont S, Schuster-Klein C, Guardiola-Lemaitre B, Pevet P, Challet E. Melatonin potentiates the effects of metformin on glucose metabolism and food intake in high-fat-fed rats Endocrinol Diabetes Metab. 2018 Oct;1(4):e00039. PMID: 30815567", "BibTeX": "@article{30815567, title={Melatonin potentiates the effects of metformin on glucose metabolism and food intake in high-fat-fed rats}, author={Dantas-Ferreira RF and Raingard H and Dumont S and Schuster-Klein C and Guardiola-Lemaitre B and Pevet P and Challet E}, journal={Endocrinol Diabetes Metab}, volume={1}, number={4}, pages={e00039}}"}}, {"_id": "28233407", "pmid": 28233407, "title": "Evaluation of a general practitioner-led cardiometabolic clinic: Physical health profile and treatment outcomes for clients on clozapine.", "journal": "Int J Ment Health Nurs", "authors": ["Coates D", "Woodford P", "Higgins O", "Grover D"], "date": "2018-02-01T00:00:00Z", "doi": "10.1111/inm.12321", "meta_date_publication": "2018 Feb", "meta_volume": "27", "meta_issue": "1", "meta_pages": "303-310", "score": 50029.28, "text_hl": "At the first appointment, the majority of clients had @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@metabolic syndrome@@@ that was mostly left untreated; many of these clients were commenced on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. The outcomes are positive, and show that the majority of clients lost weight (82.5%) and had a @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@reduction@@@ in @<m>DISEASE_MASS_syndrome</m> @DISEASE_MESH:C536030 @@@body mass@@@ index (84.6%); nearly half (44.4%) had a @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@reduction@@@ in waist @DISEASE_Abidi_X_linked_mental_retardation_syndrome @DISEASE_MESH:C535556 @@@circumference@@@. ", "citations": {"NLM": "Coates D, Woodford P, Higgins O, Grover D. Evaluation of a general practitioner-led cardiometabolic clinic: Physical health profile and treatment outcomes for clients on clozapine. Int J Ment Health Nurs. 2018 Feb;27(1):303-310. PMID: 28233407", "BibTeX": "@article{28233407, title={Evaluation of a general practitioner-led cardiometabolic clinic: Physical health profile and treatment outcomes for clients on clozapine.}, author={Coates D and Woodford P and Higgins O and Grover D}, journal={Int J Ment Health Nurs}, volume={27}, number={1}, pages={303-310}}"}}]}